What is already known about this subject?
There is a growing body of evidence that type 2 dia-betes (T2D) is a stronger risk factor for cardiovascular complications in women than in men.
We aimed to evaluate sex differences in the levels of cardiometabolic risk factors, pharmacological treatment and achievement of treatment targets for hemoglobin A1c (HbA1c), systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-c), in a large, well-phenotyped cohort of Dutch individuals with T2D.
What are the new findings?
Women, especially those with lower and middle educational levels, had a substantially higher body mass index than men, while other cardiometabolic risk factors were highly comparable.
Women were more likely to receive antihypertensive medication in the presence of high cardiovascular disease risk and increased SBP, while no differences were found for glucose-lowering or lipid-lowering medication.
Dit artikel is natuurlijk Open Access gepubliceerd. Bron en meer informatie: